A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial - Eriksson,B.I.; Dahl,O.E.; Buller,H.R. (J Thromb Haemost, 2005)